Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence study of ezetimibe 10 mg vs Ezetrol 10 mg in healthy Thai volunteers under fasting
TCTR20210707007Phase 1Not yet recruiting
- Sponsor
- Bio-innova
- Start
- Oct 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of ezetimibe in hypercholesterolemia (2 arms), sponsored by Bio-innova. Planned start Oct 2021; status: not yet recruiting.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on TCTR20210707007.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20210707007.